Understanding the role of the pain peptide CGRP has led to advances in treatment of migraine not seen since the triptans (Imitrex and others) were approved in the early 1990’s. The “gepants” (Ubrelvy and Nuretec, with more to come) and the “ditans” (Reyvow) are starting to replace the triptans as acute treatment, owing to better… Read more »
Recent Comments